Exact Mass: 275.246

Exact Mass Matches: 275.246

Found 83 metabolites which its exact mass value is equals to given mass value 275.246, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Corydendramine B

Corydendramine B

C18H29NO (275.2249)


   

Alkaloid 275A

Alkaloid 275A

C19H33N (275.2613)


   

Corydendramine A

Corydendramine A

C18H29NO (275.2249)


   
   

Hazaleamide

Hazaleamide

C18H29NO (275.2249)


   

Siphonodictidine

Siphonodictidine

C16H25N3O (275.1998)


   

NSC643727

NSC643727

C19H33N (275.2613)


   

2,4,8,11-Tetradecatetraenoic aicd isobutylamide|hazaleamide|N-isobutyl-(2E,4E,8Z,11Z)-tetradecatetraenamide

2,4,8,11-Tetradecatetraenoic aicd isobutylamide|hazaleamide|N-isobutyl-(2E,4E,8Z,11Z)-tetradecatetraenamide

C18H29NO (275.2249)


   

Crucigasterin 275

Crucigasterin 275

C18H29NO (275.2249)


   

2-Methyl-12-(3-pyridyl)dodecanal

2-Methyl-12-(3-pyridyl)dodecanal

C18H29NO (275.2249)


   

1,3-dideoxy-alpha-1-C-(8-hydroxyoctyl)mannojirimycin

1,3-dideoxy-alpha-1-C-(8-hydroxyoctyl)mannojirimycin

C14H29NO4 (275.2096)


   

2-phenyl-1,5,9-triazacyclotridecan-4-one

2-phenyl-1,5,9-triazacyclotridecan-4-one

C16H25N3O (275.1998)


   

(5E,8Z)-3-(1-non-8-enyl)-5-((E)-1-prop-1-enyl)pyrrolizidine|3-(8-Nonenyl)-5-(1-propenyl)pyrrolizidine

(5E,8Z)-3-(1-non-8-enyl)-5-((E)-1-prop-1-enyl)pyrrolizidine|3-(8-Nonenyl)-5-(1-propenyl)pyrrolizidine

C19H33N (275.2613)


   

ACMC-20mkiq

ACMC-20mkiq

C18H29NO (275.2249)


   

275C 3,5-Indolizidine (5Z,9Z)

275C 3,5-Indolizidine (5Z,9Z)

C19H33N (275.2613)


   

275B Decahydroquinoline 2-epi-cis

275B Decahydroquinoline 2-epi-cis

C19H33N (275.2613)


   

2-(1-Hex-5-enyl)-5-(1-non-8-enyl)-pyrroline

2-(1-Hex-5-enyl)-5-(1-non-8-enyl)-pyrroline

C19H33N (275.2613)


   

phenylethylamide 275

phenylethylamide 275

C18H29NO (275.2249)


   

(8S,Z)-6-((R,E)-2,5-dimethylhepta-4,6-dien-1-ylidene)-8-methyloctahydroindolizin-8-ol

(8S,Z)-6-((R,E)-2,5-dimethylhepta-4,6-dien-1-ylidene)-8-methyloctahydroindolizin-8-ol

C18H29NO (275.2249)


   

(2S,5R)-2,5-di(pent-4-en-1-yl)decahydroquinoline

(2S,5R)-2,5-di(pent-4-en-1-yl)decahydroquinoline

C19H33N (275.2613)


   

(3R,5S)-3-(hex-5-en-1-yl)-5-(pent-4-en-1-yl)octahydroindolizine

(3R,5S)-3-(hex-5-en-1-yl)-5-(pent-4-en-1-yl)octahydroindolizine

C19H33N (275.2613)


   

8-(but-3-en-1-yl)-5-(hept-6-en-1-yl)octahydroindolizine

8-(but-3-en-1-yl)-5-(hept-6-en-1-yl)octahydroindolizine

C19H33N (275.2613)


   

(E)-8-ethyl-5-(non-5-en-1-yl)-1,2,3,5,8,8a-hexahydroindolizine

(E)-8-ethyl-5-(non-5-en-1-yl)-1,2,3,5,8,8a-hexahydroindolizine

C19H33N (275.2613)


   

(5R,6R,8R,8aR)-6,8-dimethyl-5-((E)-nona-6,8-dien-1-yl)octahydroindolizine

(5R,6R,8R,8aR)-6,8-dimethyl-5-((E)-nona-6,8-dien-1-yl)octahydroindolizine

C19H33N (275.2613)


   

(5R,6R,8R,8aR)-6,8-dimethyl-5-(non-8-yn-1-yl)octahydroindolizine

(5R,6R,8R,8aR)-6,8-dimethyl-5-(non-8-yn-1-yl)octahydroindolizine

C19H33N (275.2613)


   

(3R,5S)-5-methyl-3-(non-8-yn-1-yl)octahydro-1H-pyrrolo[1,2-a]azepine

(3R,5S)-5-methyl-3-(non-8-yn-1-yl)octahydro-1H-pyrrolo[1,2-a]azepine

C19H33N (275.2613)


   

(3R,5S)-5-methyl-3-((E)-nona-6,8-dien-1-yl)octahydro-1H-pyrrolo[1,2-a]azepine

(3R,5S)-5-methyl-3-((E)-nona-6,8-dien-1-yl)octahydro-1H-pyrrolo[1,2-a]azepine

C19H33N (275.2613)


   

4-Piperidinecarboxamide,4-[(1-methylethyl)amino]-1-(phenylmethyl)-

4-Piperidinecarboxamide,4-[(1-methylethyl)amino]-1-(phenylmethyl)-

C16H25N3O (275.1998)


   

Hexadiline

Hexadiline

C19H33N (275.2613)


   

propiram

propiram

C16H25N3O (275.1998)


C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist

   

Ametoctradin

5-ethyl-6-octyl-[1,2,3]triazolo[1,5-a]pyrimidin-7-amine

C15H25N5 (275.211)


   

Tributylmethylammonium methyl carbonate

Tributylmethylammonium methyl carbonate

C15H33NO3 (275.246)


   
   

tri-n-butyl-d27 phosphate

tri-n-butyl-d27 phosphate

C12H18D9O4P (275.2212)


   

2-NITRO-2-UNDECYL-1,3-PROPANEDIOL

2-NITRO-2-UNDECYL-1,3-PROPANEDIOL

C14H29NO4 (275.2096)


   

2,4,6-Tri-t-butyl-nitrosobenzene

2,4,6-Tri-t-butyl-nitrosobenzene

C18H29NO (275.2249)


   

N,N-Diethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline

N,N-Diethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline

C16H26BNO2 (275.2056)


   

N-[2-(Diethylamino)ethyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide

N-[2-(Diethylamino)ethyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide

C16H25N3O (275.1998)


   

2,4,6-tritert-butyl-N-methylaniline

2,4,6-tritert-butyl-N-methylaniline

C19H33N (275.2613)


   

4-Piperidinecarboxamide,1-(phenylmethyl)-4-(propylamino)-

4-Piperidinecarboxamide,1-(phenylmethyl)-4-(propylamino)-

C16H25N3O (275.1998)


   

3-(isodecyloxy)propylammonium acetate

3-(isodecyloxy)propylammonium acetate

C15H33NO3 (275.246)


   

Doxylaminephenyl-d5

Doxylaminephenyl-d5

C17H17D5N2O (275.2046)


   

(1S,5R)-(-)-CIS-2-OXABICYCLO[3.3.0]OCT-6-EN-3-ONE

(1S,5R)-(-)-CIS-2-OXABICYCLO[3.3.0]OCT-6-EN-3-ONE

C17H29N3 (275.2361)


   

N-(2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZYL)PROPAN-1-AMINE

N-(2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZYL)PROPAN-1-AMINE

C16H26BNO2 (275.2056)


   

17beta-estradiol-16,16,17-d3

17beta-estradiol-16,16,17-d3

C18H21D3O2 (275.1965)


   

N-[3-(Dimethoxymethylsilyl)propyl]-1-piperazineethanamine

N-[3-(Dimethoxymethylsilyl)propyl]-1-piperazineethanamine

C12H29N3O2Si (275.2029)


   

Piperphenidol

Piperphenidol

C18H29NO (275.2249)


   

2-methoxy-4-(4-pyrrolidin-1-ylpiperidin-1-yl)aniline

2-methoxy-4-(4-pyrrolidin-1-ylpiperidin-1-yl)aniline

C16H25N3O (275.1998)


   

(6Z,9Z,12Z,15Z)-Octadeca-6,9,12,15-tetraenoate

(6Z,9Z,12Z,15Z)-Octadeca-6,9,12,15-tetraenoate

C18H27O2- (275.2011)


   

cis-Parinarate

cis-Parinarate

C18H27O2- (275.2011)


A straight-chain, unsaturated, long-chain fatty acid anion that is the conjugate base of cis-parinaric acid, arising from deprotonation of the carboxylic acid group.

   

All-cis-9,12-octadecadien-6-ynoic acid

All-cis-9,12-octadecadien-6-ynoic acid

C18H27O2- (275.2011)


   
   

(1S,2R)-5-methoxy-1-methyl-N,N-dipropyl-1,2,3,4-tetrahydronaphthalen-2-amine

(1S,2R)-5-methoxy-1-methyl-N,N-dipropyl-1,2,3,4-tetrahydronaphthalen-2-amine

C18H29NO (275.2249)


D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists

   

5-methoxy-1-methyl-N,N-dipropyl-1,2,3,4-tetrahydronaphthalen-2-amine

5-methoxy-1-methyl-N,N-dipropyl-1,2,3,4-tetrahydronaphthalen-2-amine

C18H29NO (275.2249)


   

(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

C18H27O2- (275.2011)


   

N-(2-phenylethyl)decanamide

N-(2-phenylethyl)decanamide

C18H29NO (275.2249)


   

2-Aminopentadecane-1,3,4-triol

2-Aminopentadecane-1,3,4-triol

C15H33NO3 (275.246)


   

(6Z,9Z,12Z,15Z)-Octadecatetraenoate

(6Z,9Z,12Z,15Z)-Octadecatetraenoate

C18H27O2 (275.2011)


A polyunsaturated fatty acid anion that is the conjugate base of (6Z,9Z,12Z,15Z)-octadecatetraenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

trans-parinarate

trans-parinarate

C18H27O2 (275.2011)


A straight-chain, unsaturated fatty acid anion that is the conjugate base of trans-parinaric acid, arising from deprotonation of the carboxylic acid group.

   

octadecatetraenoate

octadecatetraenoate

C18H27O2. (275.2011)


A fatty acid anion containing 18 carbons and four double bonds. Formed by deprotonation of the carboxylic acid group. Major species at pH 7.3.

   

5-methyl-3-(non-8-yn-1-yl)-octahydro-1h-pyrrolo[1,2-a]azepine

5-methyl-3-(non-8-yn-1-yl)-octahydro-1h-pyrrolo[1,2-a]azepine

C19H33N (275.2613)


   

n-[(2e,6e)-3,7-dimethyl-8-(4-methylfuran-2-yl)octa-2,6-dien-1-yl]guanidine

n-[(2e,6e)-3,7-dimethyl-8-(4-methylfuran-2-yl)octa-2,6-dien-1-yl]guanidine

C16H25N3O (275.1998)


   

(2e,4e,8z,11z)-n-(2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

(2e,4e,8z,11z)-n-(2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

C18H29NO (275.2249)


   

(2s,3s,5r)-2-benzyl-5-heptylpyrrolidin-3-ol

(2s,3s,5r)-2-benzyl-5-heptylpyrrolidin-3-ol

C18H29NO (275.2249)


   

(2s,3r,6s)-6-[(1e,3e,7e,9e)-dodeca-1,3,7,9-tetraen-1-yl]-2-methylpiperidin-3-ol

(2s,3r,6s)-6-[(1e,3e,7e,9e)-dodeca-1,3,7,9-tetraen-1-yl]-2-methylpiperidin-3-ol

C18H29NO (275.2249)


   

6-(dodeca-1,3,5,9-tetraen-1-yl)-2-methylpiperidin-3-ol

6-(dodeca-1,3,5,9-tetraen-1-yl)-2-methylpiperidin-3-ol

C18H29NO (275.2249)


   

(2e,4e,8z,11e)-n-(2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

(2e,4e,8z,11e)-n-(2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

C18H29NO (275.2249)


   

(1s,4s,9r,10r)-9-butyl-10-propyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodec-8(12)-en-6-imine

(1s,4s,9r,10r)-9-butyl-10-propyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodec-8(12)-en-6-imine

C17H29N3 (275.2361)


   

(2e,4e,8z,10z)-n-(2-methylpropyl)tetradeca-2,4,8,10-tetraenimidic acid

(2e,4e,8z,10z)-n-(2-methylpropyl)tetradeca-2,4,8,10-tetraenimidic acid

C18H29NO (275.2249)


   

(2s,3r,6s)-6-[(1e,3e,5e,9e)-dodeca-1,3,5,9-tetraen-1-yl]-2-methylpiperidin-3-ol

(2s,3r,6s)-6-[(1e,3e,5e,9e)-dodeca-1,3,5,9-tetraen-1-yl]-2-methylpiperidin-3-ol

C18H29NO (275.2249)


   

(3s,5r,9ar)-5-methyl-3-(non-8-yn-1-yl)-octahydro-1h-pyrrolo[1,2-a]azepine

(3s,5r,9ar)-5-methyl-3-(non-8-yn-1-yl)-octahydro-1h-pyrrolo[1,2-a]azepine

C19H33N (275.2613)


   

9-butyl-10-propyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodec-8(12)-en-6-imine

9-butyl-10-propyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodec-8(12)-en-6-imine

C17H29N3 (275.2361)


   

(2e,4e,8z,11e)-n-[(2s)-butan-2-yl]tetradeca-2,4,8,11-tetraenimidic acid

(2e,4e,8z,11e)-n-[(2s)-butan-2-yl]tetradeca-2,4,8,11-tetraenimidic acid

C18H29NO (275.2249)


   

n-(2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

n-(2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

C18H29NO (275.2249)


   

(2e,4e,8z,11z)-n-[(2s)-butan-2-yl]tetradeca-2,4,8,11-tetraenimidic acid

(2e,4e,8z,11z)-n-[(2s)-butan-2-yl]tetradeca-2,4,8,11-tetraenimidic acid

C18H29NO (275.2249)


   

n-[3,7-dimethyl-8-(4-methylfuran-2-yl)octa-2,6-dien-1-yl]guanidine

n-[3,7-dimethyl-8-(4-methylfuran-2-yl)octa-2,6-dien-1-yl]guanidine

C16H25N3O (275.1998)


   

2-(hex-1-en-1-yl)-5-nonylidene-1,4-dihydropyrrole

2-(hex-1-en-1-yl)-5-nonylidene-1,4-dihydropyrrole

C19H33N (275.2613)


   

6-(dodeca-1,3,7,9-tetraen-1-yl)-2-methylpiperidin-3-ol

6-(dodeca-1,3,7,9-tetraen-1-yl)-2-methylpiperidin-3-ol

C18H29NO (275.2249)


   

(3r,5s,9ar)-5-methyl-3-(non-8-yn-1-yl)-octahydro-1h-pyrrolo[1,2-a]azepine

(3r,5s,9ar)-5-methyl-3-(non-8-yn-1-yl)-octahydro-1h-pyrrolo[1,2-a]azepine

C19H33N (275.2613)


   

(2s,3s,5e,9z,12z,15z)-2-aminooctadeca-5,9,12,15,17-pentaen-3-ol

(2s,3s,5e,9z,12z,15z)-2-aminooctadeca-5,9,12,15,17-pentaen-3-ol

C18H29NO (275.2249)


   

(2r,3s,5e,9z,12z,15z)-2-aminooctadeca-5,9,12,15,17-pentaen-3-ol

(2r,3s,5e,9z,12z,15z)-2-aminooctadeca-5,9,12,15,17-pentaen-3-ol

C18H29NO (275.2249)


   

2-aminooctadeca-5,9,12,15,17-pentaen-3-ol

2-aminooctadeca-5,9,12,15,17-pentaen-3-ol

C18H29NO (275.2249)